Trulicity ® (dulaglutide) injection

0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Highlights from dulaglutide September 2020 label update

Dr. Leonard Glass summarizes in this video the label updates resulting from the approval of Trulicity® (dulaglutide) 3.0 mg and 4.5 mg doses.

Date of Last Review: October 13, 2020

Document Number: VV-MED-91055


Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Chat with us

Submit a Request

Visit Us @LillyMedical